OTS.at

Grünenthal receives FDA Orphan Drug and Rare Pediatric Disease Designations for Tegacorat for the Treatment of Duchenne Muscular Dystrophy

Grünenthal announced today that its investigational compound tegacorat (GRM-01) received Orphan Drug and Rare Pediatric Disease Designations from the US Food and Drug Administration ...
OTS.at

EQS-News: RBI on the interim status of acceptances of the voluntary public tender offer for all Addiko shares as of 6 July 2026

Tender Offer RBI on the interim status of acceptances of the voluntary public tender offer for all Addiko shares as of 6 July 2026 07.07.2026 / 08:30 CET/CEST The issuer is solely responsible for the ...
OTS.at

When pain isn’t the same for everyone

Not all pain is the same – but it is often treated as if it were. Biologist Manuela Schmidt intends to change that. She investigates tiny nerve cells to find what distinguishes a child’s pain from ...
OTS.at

EQS-Adhoc: Emerald Horizon AG: Management Board member and majority shareholder Florian Wagner commits to provide additional equity financing in the amount of EUR 20 million.

Corporate Action Emerald Horizon AG: Management Board member and majority shareholder Florian Wagner commits to provide additional equity financing in the amount of EUR 20 million. 30-Jun-2026 / 12:59 ...
OTS.at

EQS-DD: AT&S Austria Technologie & Systemtechnik AG: AIC Androsch International Management Consulting GmbH, sell

Details of the person discharging managerial responsibilities / person closely associated a) Name ┌──────────────────────┬─────────────────────────────────────────────────┐ │ Name and legal form: │ ...
OTS.at

EQS-Adhoc: EPH Group AG: EPH Group AG Extends Subscription Period for New EPH Shares Until 31 July 2026

Capital Increase/Statement EPH Group AG: EPH Group AG Extends Subscription Period for New EPH Shares Until 31 July 2026 26-Jun-2026 / 12:18 CET/CEST Disclosure of an inside information acc. to Article ...
OTS.at

EQS-DD: AT&S Austria Technologie & Systemtechnik AG: Dörflinger Management & Beteiligungs GmbH, sell

Details of the person discharging managerial responsibilities / person closely associated a) Name ┌──────────────────────┬───────────────────────────────────────────┐ │ Name and legal form: │ ...
OTS.at

FIT GROUP AG: Further Expansion of the Share's Tradability

CET/CEST Schüttorf, July 2, 2026 – FIT GROUP AG announces that the tradability of its shares for investors in Germany has been further enhanced. According to the latest information available, FIT ...
OTS.at

Grünenthal successfully completes Phase I trial with Nociceptin Receptor (NOP) Agonist

In a Phase I trial, the investigational compound was demonstrated to be safe and well tolerated. A Phase II trial will commence later this year. Grünenthal announced today that the company ...
OTS.at

EQS-News: AGRANA Preliminary results for the first quarter 2026|27

OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS - WWW.OTS.AT | ...
ots

EQS-DD: FIT GROUP AG: Diyar Acar, sell

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 29.06.2026 / 16:04 CET/CEST The issuer is solely ...